Retinopathy Organoid Modeling Service

The translation of preclinical findings into clinical success for ocular diseases is fundamentally constrained by models that fail to recapitulate the intricate neuro-sensory environment of the human retina. Inherent inter-species differences in animal models often mask human-specific pathologies, while conventional 2D cultures cannot reproduce the complex, laminated cytoarchitecture and intercellular signaling that govern retinal homeostasis and disease. This gap has significantly impeded the development of therapies for a host of debilitating retinopathies.

Creative Biolabs addresses this core challenge by engineering high-fidelity 3D retinal organoids (ROs) from human induced pluripotent stem cells (hiPSCs). Our platforms leverage the intrinsic self-organization capabilities of hiPSCs to build laminated, multi-cellular constructs that functionally and structurally mimic the human neural retina, offering a powerful, human-relevant system to dissect disease and accelerate therapeutic discovery.

Reconstructing the Human Neural Retina in a Dish

Our core competency lies in the generation and deep characterization of laminated retinal organoids (ROs) that faithfully mimic in vivo development and structure.

1. Self-Organized Lamination: Our protocol guides hiPSCs to form ROs that autonomously stratify into the key cellular layers, including a defined photoreceptor layer (PRL), inner nuclear layer (INL), and ganglion cell layer (GCL).
2. Comprehensive Cellular Diversity: These organoids contain the full complement of essential neuro-retinal cell types, each in its correct anatomical position:
   • Photoreceptors (Rods and Cones)
   • Retinal Ganglion Cells (RGCs)
   • Bipolar, Amacrine, and Horizontal Cells
   • Müller Glia
3. Advanced Photoreceptor Maturation: A key feature of our models is the development of mature photoreceptors complete with a functional connecting cilium and light-sensing outer segments (POS). This makes our ROs an exceptionally relevant platform for studying the primary cells affected in many forms of blindness.

A Validated Platform for Diverse Neuro-Retinal Pathologies

Our ROs provide robust models for a wide range of retinopathies where neuronal or glial dysfunction is the primary driver.

1. Early-Stage Diabetic Retinopathy (DR): It is now established that significant neurodegeneration and inflammation precede the well-known vascular defects in diabetic retinopathy. Our service provides a unique platform to model these critical early events. By subjecting our retinal organoids to controlled hyperglycemic (high-glucose) conditions, we create a reliable human in vitro model that mimics the initial stages of DR pathology, including key molecular and functional changes in retinal cells. This advanced model is ideal for screening novel neuroprotective and anti-inflammatory compounds aimed at preventing or delaying the progression of DR before irreversible damage occurs.
2. Inherited Retinal Diseases (IRDs): We use patient-derived iPSCs or introduce specific mutations via CRISPR-Cas9 to model monogenic blinding conditions. Our platforms are validated for studying:
   • Retinitis Pigmentosa (RP): Investigate the effects of RPGR mutations and other genetic drivers on photoreceptor survival and function.
   • Leber Congenital Amaurosis (LCA): Model how mutations in genes like CEP290 lead to defects in the photoreceptor connecting cilium and subsequent vision loss.
3. Glaucoma and Optic Neuropathies: Glaucoma is characterized by the progressive loss of retinal ganglion cells. Our ROs provide a human-specific system to model RGC apoptosis, investigate neuroprotective strategies, and screen for compounds that promote RGC survival and axonal health.
4. Age-Related Macular Degeneration (AMD) - Atrophic Form: We model the "dry" form of AMD by focusing on the health and interplay of the retinal pigment epithelium (RPE) and photoreceptors. Our models can be used to study the mechanisms of RPE dysfunction and the resulting photoreceptor degeneration characteristic of geographic atrophy.

Our Workflow

Building the Human Retina to Uncover the Future of Vision Science.

Leverage the anatomical precision of our human retinal organoids to gain unparalleled insights into disease and accelerate your journey to the clinic.

Consult Our Retinal Modeling Experts

Reference

1. Galindo-Cabello, Nadia et al. "Retinal Organoids: Innovative Tools for Understanding Retinal Degeneration." International journal of molecular sciences vol. 26,7 3263. 1 Apr. 2025, doi:10.3390/ijms26073263. Distributed under Open Access License CC BY 4.0 without modification.